I think you over-simplified what I was saying. Of course, I'm here for the whole package and would love to see value come from the other items. However, I believe the company does view the other assets as the primary means to fund MANF. I didn't think that was a big surprise to anyone. Obviously, the value of the company would increase substantially along the way along with share price. That's the ideal situation for everyone.
I still think it's a bit short-sighted to get so wrapped up in the day to day share price since you really have no idea what's going on behind the scenes, but I'll never convince you of that. My point is that they don't want MANF to hit a roadblock due to a lack of funding, so they will have to make deals along the way to ensure they secure funding for it. That's why I'm confident the other assets will pay off.
I think we agree more than you realize.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links